Acadia Pharmaceuticals Inc. (ACAD) Financials

Key financial figures for Acadia Pharmaceuticals Inc. (Q2 2026).

Revenue

$308M

Net Income

$32M

EPS

$0.18

Total Assets

$1.7B

Operating Cash Flow

$101M

Full income statement, balance sheet, and cash flow for Acadia Pharmaceuticals Inc. on SentiSense.